DoD Breast Cancer, Breakthrough Award
ID: 353142Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353142
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the DoD Breast Cancer Breakthrough Award Level 3, aimed at supporting innovative research with the potential to significantly advance breast cancer treatment and understanding. This grant program encourages high-impact research that transcends incremental advancements, requiring applicants to demonstrate a clear clinical relevance and a robust project design, while also mandating the involvement of breast cancer consumer advocates to ensure community perspectives are integrated into the research process. With an estimated total program funding of approximately $13.95 million and the expectation of awarding two grants, interested parties must submit pre-applications by May 14, 2024, and full applications by August 6, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524BCRPBTA3-GG.pdf
    The Department of Defense (DOD) is announcing an opportunity for funding through the Breast Cancer Research Program (BCRP) for fiscal year 2024, specifically targeting the Breakthrough Award Level 3. With an appropriation of $150 million, the program aims to support innovative research that addresses significant challenges in breast cancer, including prevention, understanding disease mechanisms, and improving treatment. Key deadlines include pre-application submissions by May 14, 2024, and full applications due by August 6, 2024. Eligible applicants include various organizations—both intramural and extramural—such as academic institutions and non-profits. The application process consists of a pre-application and a full application submission, requiring detailed narratives on impact, clinical relevance, and project design. Importantly, involvement from breast cancer consumer advocates is mandated to ensure community perspectives are integrated into research efforts. The program emphasizes impactful, high-potential research that transcends incremental advancements, encouraging collaborations that can leverage unique populations and infrastructures. Notably, the fund allocation is contingent on the quality and merit of the applications received and ultimately aims to drive breakthroughs in breast cancer treatment and understanding.
    Similar Opportunities
    DoD Breast Cancer, Transformative Breast Cancer Consortium Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Transformative Breast Cancer Consortium Development Award, aimed at fostering innovative research to combat breast cancer. This grant supports the establishment of a consortium framework that brings together scientists, clinicians, and breast cancer advocates to conduct preliminary research, with a focus on developing infrastructure, acquiring resources, and generating necessary preliminary data. The program emphasizes collaboration across institutions, particularly in addressing women's health issues and advancing knowledge relevant to military families and veterans. Interested applicants can apply for up to $100,000 in direct costs, with applications due by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Breast Cancer, Clinical Research Extension Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Breast Cancer Clinical Research Extension Award, a federal grant aimed at enhancing the impact of breast cancer clinical studies. This grant seeks to extend data collection and analysis from existing clinical trials, focusing on improving patient follow-up and addressing knowledge gaps due to early trial terminations. The program is critical for advancing breast cancer research and ensuring that patient contributions are effectively utilized to save lives. With an estimated total funding of $9.3 million, the award will support one application, with a maximum budget of $5 million for single Principal Investigators or $6 million for those utilizing the Partnering PI option. Interested applicants must submit a pre-application by September 12, 2024, and a full application by September 26, 2024. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity titled "DoD Peer Reviewed Cancer, Advancing Cancer Care Through Clinical Trials Award" for Fiscal Year 2024. This funding initiative aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment and management, particularly for military personnel and their families, addressing specific topic areas related to military health. With an estimated total program funding of $24 million and the expectation of awarding up to five grants, eligible applicants can submit proposals that demonstrate the feasibility and relevance of their clinical trials, with a maximum award amount of $3 million. Interested parties must submit their applications by October 15, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Peer Reviewed Cancer Convergent Science Cancer Consortium Award (CSCCA) for Fiscal Year 2024. This grant aims to foster transdisciplinary collaborations among scientists, clinicians, and consumer advocates to address urgent issues in cancer research, specifically targeting at least three distinct cancer areas while integrating diverse scientific methodologies. With an estimated total program funding of $32 million and a single award anticipated, applicants must submit a pre-application followed by a full application upon invitation, with the closing date for submissions set for October 15, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Impact Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Impact Award, aimed at funding high-impact cancer research that benefits Service Members, Veterans, and their families. This grant opportunity seeks to support mature research projects that address critical cancer issues, with a focus on translational or clinical research that demonstrates the potential for significant near-term impact on patient outcomes. With an estimated total program funding of $16 million and the expectation of awarding approximately 10 grants, applicants must submit a pre-application by June 21, 2024, followed by a full application due by September 26, 2024. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Peer Reviewed Cancer, Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Peer Reviewed Cancer Idea Award, a federal grant aimed at supporting innovative and high-risk cancer research relevant to military personnel, Veterans, and their families. This grant encourages proposals that challenge existing paradigms and explore new perspectives in cancer research, specifically excluding incremental advancements or ongoing projects. With an estimated total program funding of $16 million and the expectation of awarding approximately 20 grants, each project can receive up to $400,000 over a two-year period. Interested applicants must submit a pre-application by June 21, 2024, with full applications due later for those invited to proceed, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Rare Cancers, Resource Community Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Rare Cancers Resource and Community Development Award to support research initiatives aimed at improving outcomes for individuals with rare cancers. This grant opportunity seeks to develop clinical or preclinical datasets and research resources that address significant gaps in rare cancer research, emphasizing collaboration among researchers, patients, and clinicians, with a mandatory inclusion of patient advocates in the project planning and implementation phases. With an estimated total funding of $6.4 million available for up to five awards, each project can receive a maximum of $800,000 over a four-year period. Interested applicants must submit a pre-application followed by a full application, with the submission deadline set for September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Pancreatic Cancer, Translational Research Partnership Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Pancreatic Cancer Translational Research Partnership Award, aimed at fostering innovative collaborations between clinician investigators and research scientists to advance pancreatic cancer research. This grant supports projects that require equal contributions from both partners, focusing on critical areas such as early detection, supportive care interventions, and drug resistance mechanisms, with an emphasis on translating scientific discoveries into clinical applications. The total funding available for this opportunity is $4.8 million, with individual proposals eligible for up to $750,000, and the application process involves a two-step submission via eBRAP and Grants.gov, with a closing date of October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Combat Readiness - Medical, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Combat Readiness - Medical Translational Research Award (CRRP TRA) to support high-impact translational research aimed at enhancing medical readiness for military personnel. This funding opportunity seeks proposals that address critical areas such as battlefield diagnostics, treatments for life-threatening injuries, and operational health threats, with an emphasis on projects that leverage existing resources and demonstrate clear relevance to military health. The total estimated funding for this initiative is approximately $3.3 million, with the expectation of awarding around three grants, and key deadlines include pre-applications due by September 4, 2024, and full proposals by December 5, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.